Hadassah launches outpatient antibody cocktail to reduce COVID

In an effort to reduce the number of people who become inpatients, Hadassah-University Medical Center is now offering Jerusalemites newly infected with the coronavirus an infusion of monoclonal antibodies.The treatment – laboratory proteins that mimic the ability of the coronavirus. immune system to fight pests. Antigens, including viruses, became well known last year when former US President Donald Trump received it immediately after being diagnosed with COVID-19. Trump received Regeneron’s antibody cocktail, which was approved by the FDA in November. He touted the treatment as a “cure”. “I entered. I did not feel well. Twenty-four hours later, I was feeling good, “Trump said in a video he posted on Oct. 7.” I want everyone to receive the same treatment as your president because I feel good. Hadassah administers a similar cocktail, Bamlanivimab, developed by the American company Eli Lilly, also approved by the FDA last November, bamlanivimab is specifically directed against the peak protein of SARS-CoV-2 and designed to block the attachment of the virus and its entry into a person’s cells. intended for newly diagnosed patients who are at high risk of developing a severe case of COVID, such as those taking immunosuppressive drugs, receiving chemotherapy or dialysis, or who have had an organ transplant or lung disease. It is also available to anyone who is HIV positive over the age of 65.

“It is extremely important to let people know that they can change the natural course of this disease,” Hadassah chief executive Zeev Rotstein told The Jerusalem Post. “Before their symptoms even started, they should come. We don’t want to waste a single day. Patients must arrive at Hadassah by ambulance to make sure they don’t infect anyone else in their path. The treatment lasts about three hours, including observation. Then they go home and so far around ten patients have taken advantage of the program, which started last week and is run in conjunction with health funds and the health ministry, Rotstein said. Hadassah is the first Israeli hospital to offer such an outpatient program. Despite the high level of immunization in Israel, there are still many new cases per day, Rotstein said, adding, “We can save lives with this.